Carboxypeptidase [EPC]

Carboxypeptidase [EPC] was reported 286 times

These side effects are most commonly reported by patients taking drugs of the Carboxypeptidase [EPC] class:

# Drug class Count
0 OFF LABEL USE 69
1 UNDERDOSE 57
2 LABORATORY TEST INTERFERENCE 48
3 DRUG EFFECT INCOMPLETE 33
4 TOXICITY TO VARIOUS AGENTS 31
5 ACUTE KIDNEY INJURY 28
6 BLOOD CREATININE INCREASED 28
7 REBOUND EFFECT 28
8 DRUG INEFFECTIVE 24
9 RENAL FAILURE 24
10 MUCOSAL INFLAMMATION 16
11 ALANINE AMINOTRANSFERASE INCREASED 14
12 DEATH 14
13 FALSE POSITIVE INVESTIGATION RESULT 14
14 PRODUCT USE IN UNAPPROVED INDICATION 14
15 TOXIC EPIDERMAL NECROLYSIS 14
16 NO ADVERSE EVENT 13
17 DRUG LEVEL INCREASED 12
18 NEPHROPATHY TOXIC 11
19 PANCYTOPENIA 11
20 ASPARTATE AMINOTRANSFERASE INCREASED 10
21 NEUTROPENIA 9
22 RENAL FAILURE ACUTE 9
23 DRUG INTERACTION 8
24 ENCEPHALOPATHY 8
25 RENAL IMPAIRMENT 8
26 DRUG CLEARANCE DECREASED 7
27 FLUID OVERLOAD 7
28 THROMBOCYTOPENIA 7
29 BLOOD BILIRUBIN INCREASED 6
30 PLEURAL EFFUSION 6
31 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5
32 FLUID RETENTION 5
33 HYPERVOLAEMIA 5
34 PRESCRIBED UNDERDOSE 5
35 ABDOMINAL PAIN 4
36 BONE MARROW FAILURE 4
37 DISEASE PROGRESSION 4
38 HEPATOCELLULAR INJURY 4
39 INCORRECT DOSE ADMINISTERED 4
40 INTERNATIONAL NORMALISED RATIO INCREASED 4
41 NEUROTOXICITY 4
42 OVERDOSE 4
43 SEIZURE 4
44 SEPSIS 4
45 THERAPY CHANGE 4
46 ANAEMIA 3
47 CRYSTAL NEPHROPATHY 3
48 DRUG EFFECT DECREASED 3
49 DYSARTHRIA 3
50 HAEMODIALYSIS 3
51 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3
52 INTENTIONAL PRODUCT USE ISSUE 3
53 NON-HODGKIN^S LYMPHOMA 3
54 PYREXIA 3
55 SEPTIC SHOCK 3
56 STAPHYLOCOCCAL BACTERAEMIA 3
57 STAPHYLOCOCCAL INFECTION 3
58 SUBDURAL HAEMATOMA 3
59 VOMITING 3
60 AGITATION 2
61 ANAPHYLACTIC REACTION 2
62 ASCITES 2
63 BILIRUBIN CONJUGATED INCREASED 2
64 BLOOD ALKALINE PHOSPHATASE INCREASED 2
65 CEREBRAL HAEMORRHAGE 2
66 CEREBROVASCULAR ACCIDENT 2
67 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 2
68 CLOSTRIDIUM DIFFICILE COLITIS 2
69 CONFUSIONAL STATE 2
70 CONTINUOUS HAEMODIAFILTRATION 2
71 CRYSTALLURIA 2
72 DRUG ERUPTION 2
73 DRUG-INDUCED LIVER INJURY 2
74 DYSPHAGIA 2
75 DYSPNOEA 2
76 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2
77 HEPATIC FAILURE 2
78 HEPATIC FUNCTION ABNORMAL 2
79 HEPATOTOXICITY 2
80 HYPERKALAEMIA 2
81 HYPERTENSION 2
82 HYPOTENSION 2
83 LIVER DISORDER 2
84 LIVER INJURY 2
85 LOSS OF CONSCIOUSNESS 2
86 MENTAL STATUS CHANGES 2
87 METABOLIC ACIDOSIS 2
88 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2
89 MYELOSUPPRESSION 2
90 NO THERAPEUTIC RESPONSE 2
91 PNEUMONIA 2
92 PRODUCT AVAILABILITY ISSUE 2
93 PRODUCT QUALITY ISSUE 2
94 RASH ERYTHEMATOUS 2
95 RENAL PAIN 2
96 RESPIRATORY ARREST 2
97 RESPIRATORY FAILURE 2
98 STATUS EPILEPTICUS 2
99 THERAPEUTIC PRODUCT EFFECT DECREASED 2
100 THERAPEUTIC RESPONSE DECREASED 2
101 TOXIC ENCEPHALOPATHY 2
102 TOXIC SKIN ERUPTION 2
103 UNRESPONSIVE TO STIMULI 2
104 WEIGHT INCREASED 2
105 ALANINE AMINOTRANSFERASE ABNORMAL 1
106 ALTERED STATE OF CONSCIOUSNESS 1
107 AMNESIA 1
108 ARACHNOIDITIS 1
109 ARRHYTHMIA 1
110 ASPARTATE AMINOTRANSFERASE ABNORMAL 1
111 ASTERIXIS 1
112 ATAXIA 1
113 ATRIAL FIBRILLATION 1
114 AZOTAEMIA 1
115 BACTERAEMIA 1
116 BACTERIAL SEPSIS 1
117 BLOOD ALBUMIN DECREASED 1
118 BLOOD CHOLESTEROL ABNORMAL 1
119 BLOOD COUNT ABNORMAL 1
120 BLOOD CULTURE POSITIVE 1
121 BLOOD ELECTROLYTES ABNORMAL 1
122 BLOOD TRIGLYCERIDES ABNORMAL 1
123 BLOOD UREA INCREASED 1
124 CARDIAC ARREST 1
125 CARDIAC FAILURE 1
126 CARDIO-RESPIRATORY ARREST 1
127 CARDIORENAL SYNDROME 1
128 CEREBROSPINAL FLUID LEAKAGE 1
129 CLOSTRIDIUM DIFFICILE INFECTION 1
130 CONDITION AGGRAVATED 1
131 CONTRAINDICATED PRODUCT ADMINISTERED 1
132 CORONARY ARTERY DISEASE 1
133 COUGH 1
134 DEEP VEIN THROMBOSIS 1
135 DERMATITIS 1
136 DIALYSIS 1
137 DRUG EFFECT DELAYED 1
138 DRUG HYPERSENSITIVITY 1
139 DRUG LEVEL DECREASED 1
140 DRUG LEVEL FLUCTUATING 1
141 ELECTROLYTE IMBALANCE 1
142 EPIDERMAL NECROSIS 1
143 EROSIVE OESOPHAGITIS 1
144 EXTRA DOSE ADMINISTERED 1
145 FATIGUE 1
146 FEBRILE NEUTROPENIA 1
147 GENERAL PHYSICAL HEALTH DETERIORATION 1
148 GENITAL EROSION 1
149 GLOMERULAR FILTRATION RATE DECREASED 1
150 HAEMODYNAMIC INSTABILITY 1
151 HEADACHE 1
152 HEPATIC STEATOSIS 1
153 HEPATOMEGALY 1
154 HERPES ZOSTER 1
155 HYPERSENSITIVITY 1
156 HYPOKALAEMIA 1
157 HYPOXIA 1
158 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
159 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
160 INFUSION RELATED REACTION 1
161 INFUSION SITE REACTION 1
162 INJECTION SITE INFECTION 1
163 INTENTIONAL PRODUCT MISUSE 1
164 INTENTIONAL UNDERDOSE 1
165 LEUKAEMIC LYMPHOMA 1
166 LOWER RESPIRATORY TRACT INFECTION 1
167 MALAISE 1
168 MALIGNANT NEOPLASM PROGRESSION 1
169 MEDICATION ERROR 1
170 NAUSEA 1
171 NECK PAIN 1
172 NEUTROPHIL COUNT DECREASED 1
173 OEDEMA PERIPHERAL 1
174 OLIGURIA 1
175 ORAL MUCOSA EROSION 1
176 OSTEONECROSIS OF JAW 1
177 OSTEOSARCOMA METASTATIC 1
178 OSTEOSARCOMA RECURRENT 1
179 OXYGEN SATURATION DECREASED 1
180 PERICARDIAL EFFUSION 1
181 PNEUMOCYSTIS JIROVECII PNEUMONIA 1
182 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1
183 PRODUCT ADMINISTRATION ERROR 1
184 PRODUCT SUPPLY ISSUE 1
185 PROTHROMBIN LEVEL DECREASED 1
186 PROTHROMBIN TIME PROLONGED 1
187 PULMONARY EMBOLISM 1
188 PULMONARY OEDEMA 1
189 PULSE ABSENT 1
190 RECTAL HAEMORRHAGE 1
191 RENAL TUBULAR NECROSIS 1
192 RESUSCITATION 1
193 SKIN EXFOLIATION 1
194 SKIN INFECTION 1
195 SKIN LESION 1
196 SYSTEMIC CANDIDA 1
197 TACHYCARDIA 1
198 TRANSAMINASES INCREASED 1
199 URINARY RETENTION 1
200 URINARY TRACT INFECTION 1
201 URINE OUTPUT DECREASED 1